Innovations in Advanced Heart Failure Therapies

D7123

+ Add to Google Calendar + Add to Outlook

This conference is designed to provide an in-depth exploration of the latest advancements and strategies in the management of advanced heart failure. This conference aims to address the evolving challenges faced by healthcare professionals in diagnosing, treating, and managing complex heart failure cases, incorporating both innovative therapeutic approaches and practical management strategies.

Physicians, Surgeons, Advanced Practice Clinicians, Nurses, Respiratory Therapists and Pharmacists can benefit from attending this activity.

• 7:30 a.m. | Registration / Refreshments / Visit Exhibitors
• 7:30 – 8:15 a.m. | Product Theater Presentation (optional and not for CME credit)
• 8:45 a.m. | Welcome
  Balakrishnan Mahesh, MBBS, PhD and Nandini Nair, MD, PhD, MHL
• 9 a.m. | More Than Ejection Fraction: Comprehensive Patient Selection for Heart Transplant and LVAD
  Sonya Bressler, CRNP

  Objectives

  • Discuss the multidisciplinary evaluation process for heart transplant and LVAD candidacy.
  • Evaluate patient eligibility based on current inclusion and exclusion criteria.
  • Analyze clinical case scenarios to determine appropriate advanced heart failure therapies.
• 9:30 a.m. | Bridging the Gap: Cardio-Oncology and Advanced Heart Failure Therapies
  Omaima Ali, MD

  Objectives

  • Evaluate patients with cancer therapy–related cardiovascular disease to identify those who may benefit from advanced heart failure therapies, including durable mechanical circulatory support and heart transplantation, using a multidisciplinary cardio-oncology approach.
  • Apply evidence-based strategies to optimize patient selection, timing of referral, and collaborative management between cardio-oncology and advanced heart failure teams to improve clinical outcomes for patients with advanced heart failure in the setting of current or prior cancer.
• 10 a.m. | Morning Break / Visit Exhibitors
• 10:20 a.m. | Designing For the Exception: When Small Patients Drive Big MCS Innovation
  William Weiss, MS, PhD

  Objectives

  • Describe some of the challenges of designing devices specifically for pediatric patients.
  • Explain how developments in pediatrics can be redeployed in adult patients.
• 10:50 a.m. | From Transplant to Smart Pumps: The Evolving Landscape of Advanced Heart Failure
  Salman Zaheer, MBBS

  Objectives

  • Evaluate emerging therapies for advanced heart failure, including heart transplantation, temporary and durable mechanical circulatory support, and novel physiologically responsive device technologies, to determine appropriate patient selection, timing, and therapeutic strategy.
  • Apply contemporary evidence and multidisciplinary decision-making principles to optimize the management of patients with advanced heart failure, including treatment selection, hemodynamic assessment, complication management, and integration of innovative technologies into clinical practice.
• 11:20 a.m. | Destination MCS: Fully Implantable, Smart Devices vs Transplant – An Engineering Perspective
  Karl Bohnenberger, MS

  Objectives

  • Discuss the technical challenges of developing a fully implantable MCS device.
  • Review the MCS technical developments occurring at PSU that address the challenges of destination MCS.
• 11:50 a.m. | Integrative Use of Mechanical Circulatory Support and Heart Transplantation in Advanced Heart Failure: Optimizing Survival and Quality of Life
  Nandini Nair, MD, PhD, MHL

  Objectives

  • Evaluate contemporary indications, patient selection criteria, and timing considerations for mechanical circulatory support (MCS) and heart transplantation in individuals with advanced heart failure.
  • Analyze the role of temporary and durable MCS therapies as bridges to recovery, transplantation, or destination therapy, incorporating clinical, hemodynamic, and patient-centered factors into treatment decision-making.
  • Apply evidence-based multidisciplinary strategies to optimize post-MCS and post-transplant outcomes, including management of complications, enhancement of quality of life, and long-term survival in patients with advanced heart failure.
• 12:20 p.m. | Lunch
• 1 p.m. | What is HFpEF and is there Guideline Directed Therapy For It?
  John Boehmer, MD

  Objectives

  • Explain the clinical presentation, key risk factors, and underlying pathophysiological mechanisms of Heart Failure with Preserved Ejection Fraction (HFpEF).
  • Evaluate guideline-directed medical therapies (GDMT) and evidence-based clinical trial data for managing patients with HfpEF.
• 1:30 p.m. | Mechanical Circulatory Support in Advanced Heart Failure Care
  Balakrishnan Mahesh, MBBS, PhD

  Objectives

  • List indications for mechanical circulatory support in advanced heart failure.
  • Review temporary MCS devices.
  • Discuss implantation of durable VADs and outcomes.
• 2 p.m. | CRT Unplugged: Introducing Left Ventricular Endocardial Pacing
  Soraya Samii, MD, PhD, MBA

  Objectives

  • List the indications for CRT.
  • Explain the anatomical limitations of effective CRT.
  • Recognize a new option for improved CRT.
• 2:30 p.m. | Afternoon Break / Visit Exhibitors
• 2:45 p.m. | Cardiogenic Shock and Temporary Mechanical Circulatory Support Devices
  Amit Prasad, MD

  Objectives

  • List stages of cardiogenic shock and treatment options.
  • Differentiate between different types of temporary mechanical circulatory support devices and how they augment cardiac output.
• 3:15 p.m. | The Evolving Landscape of Cardiogenic Shock: SCAI, SHARC, and Modern Management
  Christoph Brehm, MD

  Objectives

  • Define cardiogenic shock using contemporary clinical criteria.
  • Describe the SCAI cardiogenic shock stages (A–E).
  • Explain the SHARC classification framework.
  • Recognize cardiogenic shock early.
  • Outline a contemporary management approach to cardiogenic shock.
• 3:45 p.m. | Structural Heart Interventions for Heart Failure Management
  Moses Mathur, MD, MSc

  Objectives

  • Review role of valvular structural therapies in heart failure management.
• 4:15 p.m. | Outpatient Management of LVADs and Transplants
  Lauren Morrison, CRNP, Thomas Scanlon, CRNP, Jordan Shouey, BSN, RN, VAD-C, CCRN and Tyler Thomas, CRNP

  Objectives

  • Describe best practices and challenges in outpatient management of durable LVAD patients, including device limitations, programmatic barriers, remote monitoring, log file analysis, diagnostic testing, and biomarkers to optimize pump performance and quality of life.
  • Review evidence-based strategies for outpatient heart transplant management.
  • Apply principles of immunosuppression stewardship to optimize long-term graft function and improve outcomes in heart transplant recipients.
  • Implement multidisciplinary care approaches to enhance quality of life, support long-term transplant success, promote patient engagement to improve quality after heart transplantation.
• 4:45 p.m. | Mind-Body Connection and Practical Applications for Practitioners
  Cora Tomasko, PsyD

  Objectives

  • Explore the mind-body connection in relation to Heart Failure.
  • Identify practical strategies to utilize during patient interactions.
• 5:05 p.m. | Closing Remarks / Adjournment

Nandini Nair, MD, PhD, MHL, Course Director

Balakrishnan Mahesh, MBBS, PhD, Co-Course Director

Allana Langley, MSN

Omaima Ali, MD
Associate Professor, Department of Medicine
Division of Cardiology
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

John Boehmer, MD
Professor, Department of Medicine
Heart Failure Program Director
Division of Cardiology
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Karl Bohnenberger, MS
Director, Manufacturing and Product Development
Applied Biomedical Engineering
Penn State College of Medicine
Penn State Milton S. Hershey Medical Center

Christoph Brehm, MD
Associate Professor, Department of Surgery
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Sonya Bressler, CRNP
Nurse Practitioner
Penn State Heart and Vascular Institute
Penn State Health Milton S. Hershey Medical Center

Balakrishnan Mahesh, MBBS, PhD
Associate Professor, Department of Surgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Moses Mathur, MD, MSc
Assistant Professor, Department of Medicine
Division of Cardiology
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Lauren Morrison, CRNP
MCS Transplant Advanced Practice Clinician, Heart Failure Services
Penn State Heart and Vascular Institute
Penn State Health Milton S. Hershey Medical Center

Nandini Nair, MD, PhD, MHL
Professor, Department of Medicine
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Amit Prasad, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Soraya Samii, MD, PhD, MBA
Professor of Medicine
Cardiac Electrophysiology
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Thomas Scanlon, CRNP
MCS Transplant Advanced Practice Clinician, Heart Failure Services
Penn State Heart and Vascular Institute
Penn State Health Milton S. Hershey Medical Center

Jordan Shouey, BSN, RN, VAD-C, CCRN
Lead Durable MCS Coordinator
Penn State Heart and Vascular Institute
Penn State Health Milton S. Hershey Medical Center

Tyler Thomas, CRNP
MCS Transplant Advanced Practice Clinician, Heart Failure Services
Penn State Heart and Vascular Institute
Penn State Health Milton S. Hershey Medical Center

Cora Tomasko, PsyD
Assistant Professor, Department of Psychiatry and Behavioral Health
Division of Adult Outpatient Services
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

William Weiss, MS, PhD
C. McCollister Evarts, MD Professor in Artificial Organs, Department of Surgery
Chief, Division of Applied Biomedical Engineering
Professor, Biomedical Engineering
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Salman Zaheer, MBBS
Assistant Professor, Department of Surgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in up to 6.75 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

These credits meet the criteria set by the ANCC, American Nurses Credentialing Center as contact hours that are acceptable for renewal certification. Additional information is available through the American Nurses Credentialing Center.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Please note, partial ABIM MOC points are not available for this activity. Participants will be required to attend all presentations for this activity, pass a post-test and complete an evaluation.

ABS MOC

Successful completion of this CME activity, enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

The registration fee is the same for the in-person and Internet Live Course. Reduced-fee options for medical residents and students are available for Internet Live Course participants only.

• $150 Physicians
• $120 Advanced Practice Providers
• $100 Others
• $50 Medical Residents — Internet Live Course only
• No fee Medical Students — Internet Live Course only

Please email verification of resident or student status to ContinuingEd@pennstatehealth.psu.edu

The fee includes the cost of instruction, online handout materials and all listed meals.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Thursday, Dec. 10, will incur a $25 late fee.

Cancellations received after Friday, Dec. 4, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, Dec. 8.

Accommodations are the responsibility of the program participant. A list of Hershey area lodging is available upon request or online.

Join us in Hershey

Hershey is conveniently located in central Pennsylvania, just 90 minutes from Baltimore and Philadelphia, two hours from Washington, D.C., and three hours from New York City.

• Harrisburg-Area Attractions
• Hershey Attractions
• Tanger Outlets in Hershey
• Historic Gettysburg
• Pennsylvania Dutch and Amish Country

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7123